Atlas Trials

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Clinical trial NCT00100087 · UNKNOWN

Trial details

NCT number
NCT00100087
Sponsor
Theragenics Corporation
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Macular DegenerationChoroidal Neovascularization
Start date
2004-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.